2.1. Patient selection and general information
epilepsy, shoulder fracture, peripheral neurological diseases
GROUP B, EPILEPSY
This study enrolled patients with rotor cuff repair, treated in our joint and sports medicine department between April 2022 and April 2023. The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Li Huili Hospital affiliated with Ningbo University (KY2023SL004-01).The inclusion criteria were as follows: obvious shoulder symptoms with restricted motion and no improvement of symptoms after 2 months of conservative treatment; confirmation of rotator cuff tear on magnetic resonance imaging; first-time unilateral ARCR; American Society of Anesthesiologists classification I–II; and patients and family members being aware of the study treatment plan and providing written informed consent.The exclusion criteria were as follows: history of shoulder fracture or prior surgical treatment; rotator cuff tear size >3 cm; presence of central or peripheral neurological diseases, such as epilepsy; and incomplete medical records or refusal to participate in the experimental study till completion.In total, 240 patients met the above criteria. Patients were divided into Groups A, B, and C using the random number table method, with 80 cases in each group. Group A included 26 men and 54 women aged 57.60 ± 12.09 years (range: 22–78 years) treated with ARCR alone. Group B included 31 men and 49 women aged 56.85 ± 8.32 years (range: 35–70 years) and treated with ERAS + ARCR. Group C included 30 men and 50 women aged 55.90 ± 11.98 years (range: 26–80 years) and treated with ERAS + ISB + ARCR. No significant differences were observed in age, sex, body mass index, and duration of surgery among the 3 groups (all Patient demographics and clinical indicators (n, BMI = body mass index.